Pyruvate: Metabolic protector of cardiac performance

被引:85
作者
Mallet, RT
机构
[1] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX 76107 USA
[2] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Ft Worth, TX 76107 USA
来源
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE | 2000年 / 223卷 / 02期
关键词
D O I
10.1046/j.1525-1373.2000.22319.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pyruvate, a metabolic product of glycolysis and an oxidizable fuel in myocardium, increases cardiac mechanical performance and energy reserves, especially when supplied at supraphysiological concentrations. The inotropic effects of pyruvate are most impressive in hearts that have been reversibly injured (stunned) by ischemia/reperfusion stress. Glucose appears to be an essential co-substrate for pyruvate's salutary effects in stunned hearts, but other fuels including lactate, acetate, fatty acids, and ketone bodies produce little or no improvement in postischemic function over glucose alone, In contrast to pharmacological inotropism by catecholamines, metabolic inotropism by pyruvate increases cardiac energy reserves and bolsters the endogenous glutathione antioxidant system. Pyruvate enhancement of cardiac function may result from one or more of the following mechanisms: increased cytosolic ATP phosphorylation potential and Gibbs free energy of ATP hydrolysis, enhanced sarcoplasmic reticular calcium ion uptake and release, decreased cytosolic inorganic phosphate concentration, oxyradical scavenging via direct neutralization of peroxides and/or enhancement of the intracellular glutathione/NADPH antioxidant system, and/or closure of mitochondrial permeability transition pores. This review aims to summarize evidence for each of these mechanisms and to consider the potential utility of pyruvate as a therapeutic intervention for clinical management of cardiac insufficiency.
引用
收藏
页码:136 / 148
页数:13
相关论文
共 130 条
  • [31] CARBOHYDRATE, FAT, AND PROTEIN-METABOLISM IN MUSCLE AND IN THE WHOLE-BODY AFTER MIXED MEAL INGESTION
    ELIA, M
    FOLMER, P
    SCHLATMANN, A
    GOREN, A
    AUSTIN, S
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (06): : 542 - 551
  • [32] RESPONSE OF REPERFUSION-SALVAGED, STUNNED MYOCARDIUM TO INOTROPIC STIMULATION
    ELLIS, SG
    WYNNE, J
    BRAUNWALD, E
    HENSCHKE, CI
    SANDOR, T
    KLONER, RA
    [J]. AMERICAN HEART JOURNAL, 1984, 107 (01) : 13 - 19
  • [33] EFFECTS OF PH ON MYOFILAMENTS AND SARCOPLASMIC-RETICULUM OF SKINNED CELLS FROM CARDIAC AND SKELETAL-MUSCLES
    FABIATO, A
    FABIATO, F
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1978, 276 (MAR): : 233 - 255
  • [34] CITRATE AS AN INTERMEDIARY IN INHIBITION OF PHOSPHOFRUCTOKINASE IN RAT HEART MUSCLE BY FATTY ACIDS, KETONE BODIES, PYRUVATE, DIABETES AND STARVATION
    GARLAND, PB
    RANDLE, PJ
    NEWSHOLME, EA
    [J]. NATURE, 1963, 200 (490) : 169 - +
  • [35] FAILURE OF PYRUVATE TO SALVAGE MYOCARDIUM AFTER PROLONGED ISCHEMIA
    GUTTERMAN, DD
    CHILIAN, WM
    EASTHAM, CL
    INOU, T
    WHITE, CW
    MARCUS, ML
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 250 (01): : H114 - H120
  • [36] CATECHOLAMINE-INDUCED FREE-RADICALS IN MYOCARDIAL-CELL NECROSIS ON EXPERIMENTAL STRESS IN PIGS
    HAGGENDAL, J
    JONSSON, L
    JOHANSSON, G
    BJURSTROM, S
    CARLSTEN, J
    THORENTOLLING, K
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1987, 131 (03): : 447 - 452
  • [37] MITOCHONDRIAL PYRUVATE CARRIER - KINETICS AND SPECIFICITY FOR SUBSTRATES AND INHIBITORS
    HALESTRAP, AP
    [J]. BIOCHEMICAL JOURNAL, 1975, 148 (01) : 85 - 96
  • [38] Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart
    Halestrap, AP
    Kerr, PM
    Javadov, S
    Woodfield, KY
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1366 (1-2): : 79 - 94
  • [40] MITOCHONDRIAL PYRUVATE TRANSPORT AND ITS HORMONAL-REGULATION
    HALESTRAP, AP
    SCOTT, RD
    THOMAS, AP
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1980, 11 (02): : 97 - 105